Plexus (PLXS) Expected to Announce Quarterly Earnings on Wednesday

27 Apr 2026, 01:06 by Doug Wharley · The Cerbat Gem

Plexus (NASDAQ:PLXS – Get Free Report) is expected to issue its Q2 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of $1.88 per share and revenue of $1.1309 billion for the quarter. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Parties can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, April 30, 2026 at 8:30 AM ET.

Plexus (NASDAQ:PLXS – Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The business had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.07 billion. During the same period in the previous year, the firm earned $1.73 earnings per share. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. On average, analysts expect Plexus to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Price Performance

Shares of Plexus stock opened at $254.08 on Monday. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06. Plexus has a 12 month low of $115.35 and a 12 month high of $259.05. The business has a fifty day simple moving average of $207.67 and a 200 day simple moving average of $175.96. The stock has a market cap of $6.81 billion, a PE ratio of 39.51 and a beta of 0.75.

Analyst Upgrades and Downgrades

PLXS has been the subject of a number of analyst reports. Williams Trading set a $195.00 price objective on Plexus in a research note on Wednesday, January 28th. Stifel Nicolaus set a $250.00 price objective on Plexus and gave the stock a “buy” rating in a research note on Monday, April 20th. Needham & Company LLC lifted their price objective on Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Zacks Research cut Plexus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 13th. Finally, Benchmark reissued a “buy” rating and issued a $220.00 target price on shares of Plexus in a research note on Monday, March 16th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $204.20.

Get Our Latest Report on Plexus

Insider Transactions at Plexus

In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the business’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total value of $1,921,557.40. Following the completion of the transaction, the chief operating officer directly owned 12,809 shares of the company’s stock, valued at approximately $2,579,732.60. The trade was a 42.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Todd P. Kelsey sold 8,120 shares of the business’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $205.65, for a total value of $1,669,878.00. Following the completion of the transaction, the chief executive officer directly owned 78,598 shares of the company’s stock, valued at approximately $16,163,678.70. The trade was a 9.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 50,995 shares of company stock valued at $10,345,971. Insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

A number of institutional investors have recently modified their holdings of PLXS. Johnson Financial Group Inc. bought a new stake in shares of Plexus in the third quarter valued at about $72,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after purchasing an additional 490 shares in the last quarter. Kemnay Advisory Services Inc. bought a new stake in shares of Plexus in the fourth quarter valued at about $88,000. Smartleaf Asset Management LLC lifted its holdings in shares of Plexus by 13.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 916 shares of the technology company’s stock valued at $137,000 after purchasing an additional 110 shares in the last quarter. Finally, Corient Private Wealth LLC bought a new stake in shares of Plexus in the second quarter valued at about $210,000. 94.45% of the stock is currently owned by institutional investors.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.